@article{article, title  = {{The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.}},

 publisher = {{Springer Nature}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/143453 }},

 year = {{2019}},

 month = {{10}},

 author = {{Passweg JR and Baldomero H and Basak GW and Chabannon C and Corbacioglu S and Duarte R and Kuball J and Lankester A and Montoto S and de Latour RP and Snowden JA et al}},

 doi = {{10.1038/s41409-019-0465-9}},

 volume = {{54}},

 journal = {{Bone Marrow Transplantation}},

 issue = {{10}},

 pages = {{1575-1585}},

 note = {{Accessed on 2025/11/15}}}